Australia's Optiscan Imaging gains on Mayo clinic collaboration progress
** Optiscan Imaging OIL.AX rises 6.82% to A$0.1175; marks biggest percentage gain since April 17 ** Imaging technologies maker and Mayo Clinic have come together to advance the development of a digital endomicroscopic imaging system for use in robotic surgery ** Co says development plan on track and project's next phase will take place at the Mayo Clinic's Florida campus ** OIL loses 29% this year, as of last close (Reporting by Sherin Sunny in Bengaluru) ((Sherin.Sunny@thomsonreuters.com;))
Recent news on Optiscan Imaging
See all newsBrief: Optiscan Imaging Lodges US FDA Dossier For Inspecta For Veterinary Market
Australia's Optiscan Imaging rises on deal with Australian Clinical Labs
Brief: Optiscan Imaging Enters Strategic Collaboration With Australian Clinical Labs
Brief: Optiscan Imaging Launches A$17.75M Entitlement Offer
Australia's Optiscan Imaging rises on collaboration with US-based firm